Comorbidity of substance use and other psychiatric disorders - Theoretical foundation and evidence based therapy;Komorbidität von sucht und anderen psychischen störungen - Grundlagen und evidenzbasierte therapie

Fortschritte der Neurologie Psychiatrie

Volumn 76, Issue 5, 2008, Pages 263-271

  Gouzoulis Mayfrank, Euphrosyne ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Comorbidity; Dual diagnosis; Pharmacotherapy; Psychotherapy; Substance use disorders

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; CAFFEINE; CLOZAPINE; COCAINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LITHIUM; NALTREXONAZINE; NEUROLEPTIC AGENT; NICOTINE; PLACEBO; RISPERIDONE; ZUCLOPENTHIXOL;

ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; BORDERLINE STATE; CLINICAL FEATURE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; COMORBIDITY; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; DATA BASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EVIDENCE BASED PRACTICE; GROUP THERAPY; HEALTH CARE SYSTEM; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MONOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOEDUCATION; PSYCHOPATHY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; ADDICTION; EVIDENCE BASED MEDICINE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSIS, DUAL (PSYCHIATRY); EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY; SUBSTANCE-RELATED DISORDERS;

EID: 45849144070     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038154     Document Type: Article

References (70)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627
3. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-2518
4. Moran P, Coffey C, Mann A, Carlin JB, Patton GC. Personality and substance use disorders in young adults. Br J Psychiatry 2006; 188: 374-379
5. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001; 158: 1184-1190
6. Kalbag AS, Levin FR. Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse 2005; 40: 1955-1958
7. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717-734
8. Moggi F. Etiological theories on the relationship of mental disorders and substance use disorders. In: Stohler R, Rössler W (Hrsg). Dual diagnosis: The evolving conceptual framework: Basel: Karger, 2005: 1-14
9. Iacono WG, Carlson SR, Taylor J, Elkins IJ, McGue M. Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol 1999; 11: 869-900
10. Gouzoulis-Mayfrank E. Komorbidität Psychose und Sucht - Grundlagen und Praxis. Mit Manualen für die Psychoedukation und Verhaltenstherapie. Darmstadt: Steinkopff, 2007
11. Levin FR, Hennessy G. Bipolar disorder and substance abuse. Biol Psychiatry 2004; 56: 738-748
12. Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 2004; 27: 360-374
13. Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev 2004; 23: 471-481
14. Brunette MF, Mueser KT. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. J Clin Psychiatry 2006; 67 Suppl 7: 10-17
15. Green AI, Drake RE, Brunette MF, Noordsy DL. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry 2007; 164: 402-408
16. Mangrum LF, Spence RT, Lopez M. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. J Subst Abuse Treat 2006; 30: 79-84
17. Mulrow CD, Oxman AD. Cochrane Collaboration Handbook. In: The Cochrane Collaboration. The Cochrane Library: Oxford: Update Software, 2004
18. Carroll KM. Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry 2004; 56: 778-784
19. Stohler R, Rössler W. Dual Diagnosis. The evolving conceptual framework. Basel: Karger, 2005
20. American Psychiatric Association (APA). Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Washington, DC: American Psychiatric Association, 1995: 1-59
21. Petrakis IL, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull 2006; 32: 644-654
22. Stuyt EB, Sajbel TA, Allen MH. Differing Effects of Antipsychotic Medications on Substance Abuse Treatment Patients with Co-occurring Psychotic and Substance Abuse Disorders. Am J Addict 2006; 15: 166-173
23. Brunette MF, Drake RE, Xie H, McHugo GJ, Green AI. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull 2006; 32: 637-643
24. Rubio G, Martinez I, Ponce G, Jimenez-Arriero MA, Lopez-Munoz F, Alamo C. Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Can J Psychiatry 2006; 51: 531-539
25. Sayers SL, Campbell EC, Kondrich J, Mann SC, Cornish J, O'Brien C, Caroff SN. Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol. J Nerv Ment Dis 2005; 193: 379-386
26. Cornelius JR, Clark DB, Bukstein OG, Salloum IM. Treatment of co-occurring alcohol, drug, and psychiatric disorders. Recent Dev Alcohol 2005; 17: 349-365
27. Brady KT, Verduin ML. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005; 40: 2021-2041
28. Brown ES. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 2006; 67: e05
29. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005; 62: 37-45
30. Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? J Child Adolesc Psychopharmacol 2005; 15: 787-798
31. Petrakis IL, O'Malley S, Rounsaville B, Poling J, Hugh-Strong C, Krystal JH. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology 2004; 172: 291-297
32. Petrakis IL, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull 2006; 32: 644-654
33. Petrakis IL, Poling J, Levinson C, Nich C, Canoll K, Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 2005; 57: 1128-1137
34. Miller WR, Rollnick S. Motivational Interviewing. New York: Guilford Press, 1991
35. Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry 2004; 56: 803-809
36. Daley DC, Salloum IM, Those M. Integrated treatment using a recovery-oriented approach. In: Westermeyer J, Weiss RD, Ziedonis DM (Hrsg). Integrated treatment for mood and substance use disorders. Baltimore: The Johns Hopkins University Press, 2003: 68-89
37. Ziedonis DM, Krejti JA. Dual recovery therapy: Blending psychotherapies for depression and addiction. In: Westermeyer J, Weiss RD, Ziedonis DM (Hrsg). Integrated treatment for mood and substance use disorders. Baltimore: The Johns Hopkins University Press, 2003: 90-121
38. Bowen RC, D'Arcy C, Keegan D, Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav 2000; 25: 593-597
39. Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res 2001; 25: 210-220
40. Avants SK, Margolin A, Kosten TR, Rounsaville BJ, Schottenfeld RS. When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychol 1998; 66: 924-931
41. Najavits LM. Seeking Safety - A treatment manual for PTSD and substance abuse. New York: Guilford Press, 2002
42. Najavits LM, Gallop RJ, Weiss RD. Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. J Behav Health Serv Res 2006; 33: 453-463
43. Back SE, Dansky BS, Carroll KM, Foa EB, Brady KT. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat 2001; 21: 35-45
44. Schafer I, Najavits LM. Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse. Curr Opin Psychiatry 2007; 20: 614-618
45. Linehan MM, Schmidt III H, Dimeff LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 1999; 8: 279-292
46. Linehan MM, Dimeff LA, Reynolds SKComptois KA, Welch SS, Heagerty P, Kivlahan DR. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 2002; 67: 13-26
47. Mayer-Bruns F, Lieb K, Dannegger E, Jacob GA. Dialektisch- behaviorale Therapie in der stationären Alkoholentwöhnung. Nervenarzt 2005; 76: 339-343
48. Ball SA. Manualized treatment for substance abusers with personality disorders: dual focus schema therapy. Addict Behav 1998; 23: 883-891
49. Ball SA, Cobb-Richardson P, Connolly AJ, Bujosa CT, O'Neall TW. Substance abuse and personality disorders in homeless drop-in center clients: symptom severity and psychotherapy retention in a randomized clinical trial. Compr Psychiatry 2005; 46: 371-379
50. Ball SA. Comparing individual therapies for personality disordered opioid dependent patients. J Personal Disord 2007; 21: 305-321
51. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589-608
52. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001; 158: 1706-1713
53. Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial. Br J Psychiatry 2003; 183: 418-426
54. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Can VJ. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry 2006; 188: 439-448
55. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006; 63: 426-432
56. Hulse GK, Tait RJ. Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug Alcohol Rev 2002; 21: 105-112
57. Swanson AJ, Pantalon MV, Cohen KR. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Dis 1999; 187: 630-635
58. Martino S, Carroll KM, O'Malley SS, Rounsaville BJ. Motivational interviewing with psychiatrically ill substance abusing patients. Am J Addict 2000; 9: 88-91
59. Kavanagh DJ, Young R, White A, Saunders JB, Wallis J, Shockley N, Jenner L, Clair A. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev 2004; 23: 151-155
60. Graeber DA, Moyers TB, Griffith G, Guajardo E, Tonigan S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Ment Health J 2003; 39: 189-202
61. Martino S, Carroll KM, Nich C, Rounsaville BJ. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction 2006; 101: 1479-1492
62. Santa Ana EJ, Wulfert E, Nietert PJ. Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence. J Consult Clin Psychol 2007; 75: 816-822
63. D'Amelio R, Behrendt B, Wobrock T. Psychoedukation Schizophrenie und Sucht - Manual zur Leitung von Patienten- und Angehörigengruppen. München: Urban & Fischer Elsevier, 2007
64. Schnell T, Gouzoulis-Mayfrank E. KomPASs: Komorbidität Psychose und Abhängigkeit: Skills Training. In: Gouzoulis-Mayfrank E (Hrsg). Komorbidität Psychose und Sucht - Grundlagen und Praxis. Mit Manualen für die Psychoedukation und Verhaltenstherapie. Darmstadt: Steinkopff, 2007: 105-172
65. Mueser KT, Fox L. A family intervention program for dual disorders. Community Ment Health J 2002; 38: 253-270
66. Weiss RD, Najavits LM, Greenfield SF. A relapse prevention group for patients with bipolar and substance use disorders. J Subst Abuse Treat 1999; 16: 47-54
67. Weiss RD. Treating patients with bipolar disorder and substance dependence: lessons learned. J Subst Abuse Treat 2004; 27: 307-312
68. Weiss RD, Griffin ML, Kolodziej ME, Griffin ML, Kolodziej ME, Daley DC, Doreau HR, Hennen JA. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007; 164: 100-107
69. Aviram RB, Rhum M, Levin FR. Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder. J Psychother Pract Res 2001; 10: 179-186
70. Hesslinger B, Tebartz EL van, Nyberg E, Dykierek P, Richter H, Berner M, Ebert D. Psychotherapy of attention deficit hyperactivity disorder in adults - a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 2002; 252: 177-184